124 related articles for article (PubMed ID: 25312327)
1. Selective expression of transgene using hypoxia-inducible trans-splicing group I intron ribozyme.
Kim SJ; Lee SW
J Biotechnol; 2014 Dec; 192 Pt A():22-7. PubMed ID: 25312327
[TBL] [Abstract][Full Text] [Related]
2. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.
Kwon BS; Jung HS; Song MS; Cho KS; Kim SC; Kimm K; Jeong JS; Kim IH; Lee SW
Mol Ther; 2005 Nov; 12(5):824-34. PubMed ID: 16040278
[TBL] [Abstract][Full Text] [Related]
3. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme.
Song MS; Lee SW
FEBS Lett; 2006 Sep; 580(21):5033-43. PubMed ID: 16949075
[TBL] [Abstract][Full Text] [Related]
4. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme.
Song MS; Jeong JS; Cho KS; Lee SW
Exp Mol Med; 2007 Dec; 39(6):722-32. PubMed ID: 18160843
[TBL] [Abstract][Full Text] [Related]
5. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.
Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW
Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
Jeong JS; Lee SW; Hong SH; Lee YJ; Jung HI; Cho KS; Seo HH; Lee SJ; Park S; Song MS; Kim CM; Kim IH
Clin Cancer Res; 2008 Jan; 14(1):281-90. PubMed ID: 18172280
[TBL] [Abstract][Full Text] [Related]
7. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
Hong SH; Jeong JS; Lee YJ; Jung HI; Cho KS; Kim CM; Kwon BS; Sullenger BA; Lee SW; Kim IH
Mol Ther; 2008 Jan; 16(1):74-80. PubMed ID: 17700543
[TBL] [Abstract][Full Text] [Related]
8. In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells.
Lee SJ; Lee SW; Jeong JS; Kim IH
Methods Mol Biol; 2010; 629():307-21. PubMed ID: 20387158
[TBL] [Abstract][Full Text] [Related]
9. Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement.
Won YS; Jeong JS; Kim SJ; Ju MH; Lee SW
Cancer Lett; 2015 Jan; 356(2 Pt B):918-28. PubMed ID: 25444904
[TBL] [Abstract][Full Text] [Related]
10. Selective regression of cells expressing mouse cytoskeleton-associated protein 2 transcript by trans-splicing ribozyme.
Kim A; Ban G; Song MS; Bae CD; Park J; Lee SW
Oligonucleotides; 2007; 17(1):95-103. PubMed ID: 17461766
[TBL] [Abstract][Full Text] [Related]
11. Cancer-specific induction of adenoviral E1A expression by group I intron-based trans-splicing ribozyme.
Won YS; Lee SW
J Microbiol Biotechnol; 2012 Mar; 22(3):431-5. PubMed ID: 22450801
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell targeting with mouse TERT-specific group I intron of Tetrahymena thermophila.
Ban G; Song MS; Lee SW
J Microbiol Biotechnol; 2009 Sep; 19(9):1070-6. PubMed ID: 19809268
[TBL] [Abstract][Full Text] [Related]
13. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
Si YJ; Guang LX; Yuan FH; Zhang KB
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
[TBL] [Abstract][Full Text] [Related]
14. Small Animal PET Imaging of hTERT RNA-Targeted HSV1-tk Gene Expression with
Seo MJ; Park JH; Lee KC; Lee YJ; Lee TS; Choi TH; Lee SW; Kim KI; Kang JH
Cancer Biother Radiopharm; 2020 Feb; 35(1):26-32. PubMed ID: 31746630
[No Abstract] [Full Text] [Related]
15. Use of tumor-targeting trans-splicing ribozyme for cancer treatment.
Lee SW; Jeong JS
Methods Mol Biol; 2014; 1103():83-95. PubMed ID: 24318888
[TBL] [Abstract][Full Text] [Related]
16. Ribozyme-mediated selective killing of cancer cells expressing carcinoembryonic antigen RNA by targeted trans-splicing.
Jung HS; Lee SW
Biochem Biophys Res Commun; 2006 Oct; 349(2):556-63. PubMed ID: 16945335
[TBL] [Abstract][Full Text] [Related]
17. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing.
Ryu KJ; Kim JH; Lee SW
Mol Ther; 2003 Mar; 7(3):386-95. PubMed ID: 12668134
[TBL] [Abstract][Full Text] [Related]
18. [Construction of a trans-splicing ribozyme for restoring EGFP truncation mutation].
Li B; Xiong YQ; Tu HB; Liu QC; Zou DT; Zhou WQ; Chen YY
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):748-53. PubMed ID: 16285516
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
20. Conditional and target-specific transgene induction through RNA replacement using an allosteric trans-splicing ribozyme.
Kim J; Jeong S; Kertsburg A; Soukup GA; Lee SW
ACS Chem Biol; 2014 Nov; 9(11):2491-5. PubMed ID: 25265474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
